Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS). (Q54326002)
Jump to navigation
Jump to search
scientific article published in February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS). |
scientific article published in February 2013 |
Statements
Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS). (English)
Upendra Kaul
Jagmohan Varma
Dhiman Kahali
M S Hiremath
Sameer Dani
Jamshed Dalal
P Ramchandran
Rajendra Rane
Hanmant Barkate
Chhavi Jindal
1 February 2013
61
2
97-101